Patient preferences in papillary thyroid microcarcinoma management are driven by aversion toward complications rather than treatment pathway
Quality-adjusted life year weights were comparable between the uncomplicated versions all 4 treatment pathways, suggesting that patient treatment preferences for papillary thyroid microcarcinoma are driven by aversion to treatment complications, rather than an inclination toward the experience of the treatments themselves. These quality-adjusted life year weights may be readily incorporated into value assessments for papillary thyroid microcarcinoma treatments.
Authors
- Julia F. Slejko (ORCID: https://orcid.org/0000-0001-6900-9220)
- C. Daniel Mullins (ORCID: https://orcid.org/0000-0003-4322-2490)
- Carrie Cunningham (ORCID: https://orcid.org/0000-0002-6786-5477)
- Rebecca Kowalski (ORCID: https://orcid.org/0000-0002-5191-3710)
- Yinin Hu (ORCID: https://orcid.org/0000-0002-4324-9530)
- Aprill N. Park (ORCID: https://orcid.org/0009-0000-1697-9581)
- Kendyl Carlisle (ORCID: https://orcid.org/0000-0002-4139-3686)
- Salome Ricci
- Reuben Don
Institutions
- University of Maryland, Baltimore (US)
- Mass General Brigham (US)
Publication Details
- Journal
- Surgery
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1016/j.surg.2025.109694
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute on Aging
- National Cancer Institute
- National Center for Advancing Translational Sciences